The Myositis Autoantibody Phenotypes of the Juvenile Idiopathic Inflammatory Myopathies
Authors:
- Lisa G. RiderLRLisa G. Rider
- Mona ShahMSMona Shah
- Gulnara MamyrovaGMGulnara Mamyrova
- Adam M. HuberAHAdam M. Huber
- Madeline Murguia RiceMRMadeline Murguia Rice
- Ira N. TargoffITIra N. Targoff
- Frederick W. MillerFMFrederick W. Miller
Open Access
- 1 July 2013
- journal article
- Published by Wolters Kluwer Health in Medicine
- Vol. 92 (4) , 223-243
Abstract
The juvenile idiopathic inflammatory myopathies (JIIM) are systemic autoimmune diseases characterized by skeletal muscle weakness, characteristic rashes, and other systemic features. In follow-up to our study defining the major clinical subgroup phenotypes of JIIM, we compared demographics, clinical features, laboratory measures, and outcomes among myositis-specific autoantibody (MSA) subgroups, as well as with published data on adult idiopathic inflammatory myopathy patients enrolled in a separate natural history study. In the present study, of 430 patients enrolled in a nationwide registry study who had serum tested for myositis autoantibodies, 374 had either a single specific MSA (n = 253) or no identified MSA (n = 121) and were the subject of the present report. Following univariate analysis, we used random forest classification and exact logistic regression modeling to compare autoantibody subgroups. Anti-p155/140 autoantibodies were the most frequent subgroup, present in 32% of patients with juvenile dermatomyositis (JDM) or overlap myositis with JDM, followed by anti-MJ autoantibodies, which were seen in 20% of JIIM patients, primarily in JDM. Other MSAs, including anti-synthetase, anti-signal recognition particle (SRP), and anti-Mi-2, were present in only 10% of JIIM patients. Features that characterized the anti-p155/140 autoantibody subgroup included Gottron papules, malar rash, "shawl-sign" rash, photosensitivity, cuticular overgrowth, lowest creatine kinase (CK) levels, and a predominantly chronic illness course. The features that differed for patients with anti-MJ antibodies included muscle cramps, dysphonia, intermediate CK levels, a high frequency of hospitalization, and a monocyclic disease course. Patients with anti-synthetase antibodies had higher frequencies of interstitial lung disease, arthralgia, and "mechanic's hands," and had an older age at diagnosis. The anti-SRP group, which had exclusively juvenile polymyositis, was characterized by high frequencies of black race, severe onset, distal weakness, falling episodes, Raynaud phenomenon, cardiac involvement, high CK levels, chronic disease course, frequent hospitalization, and wheelchair use. Characteristic features of the anti-Mi-2 subgroup included Hispanic ethnicity, classic dermatomyositis and malar rashes, high CK levels, and very low mortality. Finally, the most common features of patients without any currently defined MSA or myositis-associated autoantibodies included linear extensor erythema, arthralgia, and a monocyclic disease course. Several demographic and clinical features were shared between juvenile and adult idiopathic inflammatory myopathy subgroups, but with several important differences. We conclude that juvenile myositis is a heterogeneous group of illnesses with distinct autoantibody phenotypes defined by varying clinical and demographic characteristics, laboratory features, and outcomes.Keywords
This publication has 37 references indexed in Scilit:
- Anti-PL-7 (Anti-Threonyl-tRNA Synthetase) Antisynthetase SyndromeMedicine, 2012
- Interaction of HLA-DRB1*03 and smoking for the development of anti-Jo-1 antibodies in adult idiopathic inflammatory myopathies: a European-wide case studyAnnals of the Rheumatic Diseases, 2012
- Anti-MJ/NXP-2 autoantibody specificity in a cohort of adult Italian patients with polymyositis/dermatomyositisArthritis Research & Therapy, 2012
- Clinical heterogeneity and prognostic features of South Australian patients with anti‐synthetase autoantibodiesInternal Medicine Journal, 2011
- Anti-Signal Recognition Particle Myopathy in the First Decade of LifePediatric Neurology, 2011
- Autoimmune myopathies: autoantibodies, phenotypes and pathogenesisNature Reviews Neurology, 2011
- Novel autoantibodies and clinical phenotypes in adult and juvenile myositisArthritis Research & Therapy, 2011
- Autoantibodies to a 140‐kd protein in juvenile dermatomyositis are associated with calcinosisArthritis & Rheumatism, 2009
- Clinical and immunogenetic features of patients with autoantibodies to asparaginyl–transfer RNA synthetaseArthritis & Rheumatism, 2007
- Prevalence and clinical characteristics of anti-Mi-2 antibodies in Japanese patients with dermatomyositisJournal of Dermatological Science, 2005